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Single Center Outcomes of Status
Epilepticus at a Paediatric Intensive
Care Unit
Samir Shah, Namrata Shah, Robert Johnson, Alina Nico West, Narayan Prasad
ABSTRACT: Background: Status epilepticus (SE) is a frequent admission diagnosis to paediatric intensive care units (PICUs) and is
associated with variable outcomes. We have audited our experience of patients presenting in SE at a Canadian PICU to determine
unfavorable outcome variables. Methods: Charts of patients <18 years of age presenting in SE to a tertiary care PICU over a 10-year period
were audited. Data were analyzed at three care-points: transport, the emergency department (ED) and the PICU. Patient outcome before
PICU discharge was categorized as “favorable” for return to pre-status functioning level or “unfavorable” for new deficit/death. Student’s
t-test and the Kruskal-Wallis test were used for analysis of normal and skewed continuous variables, respectively, and either Chi-square test
or Fisher’s exact test for categorical variables. Results: 189 patients (54% males) were identified with a median age of 1.9 years. Idiopathic
SE had the highest incidence; infectious/vascular etiologies were associated with more unfavorable outcomes. Progression to refractory SE
in the ED had a higher incidence of death (p < 0.05). Patients with an unfavorable outcome had a higher incidence of apnea during transport
(p = 0.01), longer hospital stays (p < 0.05), need for therapeutic coma (p = 0.01), longer duration of therapeutic coma (p < 0.05), need for
mechanical ventilation (p < 0.05), and recurrent or refractory seizures during inpatient stay (p < 0.05). Multivariate analysis of unfavorable
outcomes of patients in SE presenting to the PICU included renal failure, cerebral edema, apnea during transport, refractory seizures, and
recurrent seizures. Conclusions: Refractory seizures in children presenting with SE are associated with worsened outcomes in the PICU.
RÉSUMÉ: Résultats cliniques chez des patients en état de mal épileptique admis dans une unité de soins intensifs pédiatriques. Contexte: L’état de
mal épileptique (EME) est un diagnostic fréquent dont l’issue est variable, lors de l’hospitalisation de patients dans une unité de soins intensifs pédiatriques
(USIP). Nous avons revu notre expérience chez les patients présentant un EME admis dans une USIP canadienne afin de déterminer quelles sont les variables
associées à une issus défavorable. Méthode: Nous avons examiné les dossiers des patients âgés de moins de 18 ans admis en EME dans une USIP tertiaire au
cours d’une période de 10 ans. Nous avons analysé les données recueillies au moment du transport, à la salle d’urgence (SU) et pendant le séjour à l’USIP. Les
résultats cliniques avant le congé de l’USIP ont été classés comme étant « favorables » si le patient recouvrait son niveau de fonctionnement antérieur ou
« défavorables » s’il présentait de nouveaux déficits ou s’il était décédé. Les variables continues à distribution normale ou asymétrique ont été analysées au
moyen du test t de Student et du test de Kruskal-Wallis respectivement et soit du test du chi-carré ou de la méthode exacte de Ficher pour les variables
qualitatives. Résultats: Nous avons identifié 189 patients, dont 54% étaient des garçons et dont l’âge médian était de 1,9 an. L’EME idiopathique avait
l’incidence la plus élevée et les étiologies infectieuses ou vasculaires étaient associées à des résultats plus défavorables. Une progression vers un EME à la SU
comportait une incidence de décès plus élevée (p < 0,05). Chez les patients chez qui le résultat clinique était défavorable nous avons observé une incidence plus
élevée d’apnée pendant le transport (p = 0,01), un séjour hospitalier plus long (p = 0,05), la nécessité de recourir à un coma thérapeutique (p = 0,01), une durée
plus longue du coma thérapeutique (0,05), le recours à la ventilation mécanique (p = 0,05) et des crises récidivantes ou réfractaires au traitement pendant le
séjour hospitalier (p = 0,05). L’analyse multivariée des résultats cliniques défavorables chez les patients en EME admis à l’USIP a mis en évidence les résultats
défavorables suivants: l’insuffisance rénale, l’œdème cérébral, l’apnée pendant le transport, les crises réfractaires au traitement et les crises récurrentes.
Conclusions: Les crises réfractaires au traitement chez les enfants admis en EME sont associées à une détérioration de l’état du patient à l’USIP.

doi:10.1017/cjn.2015.307

Status epilepticus (SE) is the most common neurological
emergency in childhood, with a risk of long-term neurological
sequelae.1-3 Status epilepticus has been defined as a single
epileptic seizure >30 minutes (min) in duration or two or more
sequential seizures during which function is not regained.4
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In clinical practice, however, shorter temporal criteria for
generalized convulsive SE in adults and older children (more than
five years of age) have been suggested.5,6 Currently, the most
common thresholds for considering prolonged seizures as SE are
5 and 30 minutes.7
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Epidemiological studies identify the incidence of SE to be
the highest for children under the age of one year1,8 and ranging
from 10-27/100,000.7 Status epilepticus etiology is poorly
understood and tends to be a multifactorial condition, although
the most common cause is infection.7 A population-based
prospective cohort study from Finland suggests that more than
one quarter of children with newly diagnosed epilepsy will
experience SE, and nearly half of patients with one attack will
experience a subsequent attack. The risk of SE has been deemed
to be highest early in the course of paediatric epilepsy. Status
epilepticus occurred prior to onset of epilepsy in over 73% of
cases, and within two years of onset in 90% of cases.9 Status
epilepticus associated with epilepsy is approximately 15%,
according to one observational study.10 A substantial proportion
(16%) of children with first ever-convulsive status epilepticus will
have a recurrence within a year. Those with a previous neurological abnormality are more likely to have a recurrence.11 Risk
factors that are strongly associated with SE recurrence include age
at time of onset, remote symptomatic etiology, and epilepsy
syndrome.12 Overall, prognosis is dependent on the underlying
etiology and seizure persistence.13
Systematic studies on seizure duration in children have been
few. On analysis of seizure duration in paediatric patients from
ambulance and emergency room records, Shinnar, et al. found that
while the mean seizure duration was approximately 12 minutes,
12% of cases presented with seizures lasting >30 minutes. Overall, the data suggested that if the seizure lasted for more than seven
minutes there is 95% probability that it can be categorized with
seizures that last for more than 30 minutes.14
Status Epilepticus outcomes from paediatric intensive care unit
(PICU) accounting for variables such as transportation times,
emergency department (ED) intervention, and intensive care unit
(ICU) management have not yet been described. Children
in SE who are admitted to the PICU are likely to represent
the severe end of the spectrum of outcomes, which may reflect
either the underlying cause, the treatment of SE, or both.15 While
studies have described the mortality associated with SE, no
studies have described the ICU-related morbidity and outcome
of patients with SE. Overall mortality due to SE has declined
over the past two decades because of more aggressive treatment
occurring outside hospitals and stricter hospital management
with clear, time-defined protocols.15 Nonetheless, prolonged
SE has the potential for ICU-related morbidity, including
increased duration of mechanical ventilation, hemodynamic
instability, and multi-organ dysfunction.16 There are no published
studies at this time evaluating SE and long-term neuropsychological outcomes.
Patient transportation and ED management can further affect SE
outcomes due to temporal delays. Transport times for critically ill
children in SE to tertiary care centers across Canada can be variable,
with potentially longer transport times in prairie provinces. The
purpose of this study was to explore the possible role of etiology of
SE during the ICU course, and its effect on short-term neurological
outcome of children admitted with SE to a tertiary care Canadian
prairie PICU. We hypothesize that SE associated with prolonged
transport times and PICU stay will lead to poor prognoses, including
long-term neurological outcomes and increased morbidity. Data
from PICU admissions for SE may clarify some of these issues and
potentially facilitate the development of strategies to decrease the
duration of SE and its complications.
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METHODS
We completed a retrospective audit of all PICU admissions
at the Children’s Hospital of Winnipeg over a 10-year period
(1994-2004). Institutional Review Board approval was obtained for
the study. Patients under 18 years of age admitted to the PICU at the
Children’s Hospital of Winnipeg, Manitoba with prolonged (>30
min) convulsive seizures were identified using a PICU-maintained
database. Any patient with a diagnosis of SE that required admission to the PICU was included in the study, with the exception of
those children with prolonged febrile seizures.
Demographic data, including age, weight, gender, and postal
code were collected. The postal code was used to determine the
location of a patient’s residence (within Winnipeg or outside
the city) for transport information. Patients from Winnipeg were
defined as Group A and patients from outside Winnipeg were
labeled as Group B. Data were collected on treatment administered
prior to transport to the Children’s Hospital, including treatment
at home or within the community, at a nursing station, or at a
community hospital. In addition, pre-PICU admission treatment
details were documented, including anti-epileptic drugs (AEDs)
that were administered, time of administration, and doses.
Transport data, as available, beginning from the initial site of
SE management, were recorded as follows: time required for
transport to Children’s Hospital, and the time of administration,
doses and names of the AEDs given. Apnea, failed intubations,
seizure evolution to SE, and refractory SE (defined as SE that did
not respond to initial treatment with a first-line AED, such as
benzodiazepine, plus any additional AED) were documented
during transport, in the ED, and in the PICU. Durations of
PICU and hospital stay were recorded. Seizure duration was
calculated from hospital records. In addition, information about
recurrent seizures was noted, including number of events and
response to treatment. Complications of SE assessed in the PICU
included: sepsis, renal failure, hyperthermia, cardiac arrhythmias,
hypotension, pulmonary edema, hypoglycemia, cerebral edema,
rhabdomyolysis, hepatic failure, disseminated intravascular
coagulation, apnea, anemia, syndrome of inappropriate antidiuretic hormone (SIADH), hypertension, and respiratory failure.
Details of therapeutic coma in PICU were recorded, including
drugs administered, duration of coma, duration of mechanical
ventilation, and complications occurring secondary to mechanical
ventilation. Outcome-related information recorded on patient
discharge was divided into two categories based on whether
the patient returned to baseline or developed new neurological
deficits. New neurological deficits ranged from parental descriptions
of behavioral deviations from pre-SE baseline to new abnormal
neurological examination findings or new cognitive difficulties. The
total number of deaths was also recorded.
Statistical analysis was performed using Student’s t-test for
normal continuous variables. Medians and interquartile ranges
were reported for highly skewed variables related to duration
(transport times, seizure duration, time to first AED, time in
the ED, length of PICU stay, therapeutic coma duration,
mechanical ventilation duration, length of hospital stay).
Non-parametric analysis using the Kruskal-Wallis test was used
for outcome variables and postal code variability. The Chi-square
test and Fisher’s exact test were used to analyze proportional
variables, including transport complications, ED and PICU
complications, and imaging rates for computed tomography (CT),
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Risk Factor-Outcome Association
Outcome data were available on 189 patients: 132 (69.5%)
returned to neurological baseline, 46 (24.3%) developed
new neurological deficits, and 12 (6.3%) died in the hospital
(ED, PICU) either as a consequence of SE or ensuing complications
in the PICU. Risk factors associated with unfavorable outcomes of
SE patients admitted to the PICU included recurrent seizures
refractory to standard management, development of systemic
complications of renal failure, cerebral edema, apnea during
transport, and the occurrence of recurrent breakthrough seizures
requiring treatment during their hospital stay (Table 1).

Figure 1: The etiology of paediatric status epilepticus at a single center
PICU in Winnepeg, MB, Canada. Total number of patients (n) = 189.

magnetic resonance imaging (MRI), and electroencephalography
(EEG). A p-value of <0.05 was considered significant for
all analyses.
RESULTS
Of 230 patient charts reviewed, 189 patients met study criteria.
Forty patients were excluded because of febrile seizures lasting
less than 30 minutes, a seizure diagnosis was ruled out, or the
chart data were incomplete. Forty patients were excluded due to
febrile seizures lasting less than 30 minutes, a seizure diagnosis
was ruled out, or the chart data were incomplete.
Demographics
The median age of the patients was 1.88 years (interquartile
range 0.83-5.00). These children had a median weight of 12.00 kg
(interquartile range 8.68-20.00). Of the 189 patients, 103 (54.21%)
were male, and 87 (45.79%) were female.

Transportation Times and Interventions in Relation to
Outcome
One hundred twenty five patients were from Winnipeg
(Group A; 69.44%), while 55 (30.56%) were from outside
Winnipeg (Group B). Both gender distribution and age were
comparable between the two groups. The time required for
transport from the location of initial management to the Children’s
Hospital could be determined for 121 patients (Table 2a).
In addition, length of ED stay was also tabulated (Table 2a).
Transportation times did not appear to influence outcome variables in the univariate analysis, despite there being a significant
(expected) difference in mean transport times between patients
arriving to the tertiary care center from Winnipeg versus those
residents outside Winnipeg (0.45 hr vs. 2.05 hr, p < 0.0001).
Complications during transport that adversely affected the
outcome included the occurrence of apnea (Table 2b), septic
shock, and dysrhythmias. Most patients who developed new
deficits experienced apnea during transport (34%). During transport, the initial AED dose was inadequate in 34 patients (Table 2b;
15.38% in Group A, 13.64% in Group B). However, most of these
patients returned to baseline and did not have a significant effect
on outcome. Overall, SE mortality in transport was due to
respiratory distress during apneic episodes in transport or in the
ED or complications from refractory SE, yet this data was not
statistically significant (Table 2b).

Etiology
Status epilepticus in the ICU is heterogeneous in etiology
(Figure 1). While atypical febrile seizures (febrile status epileptics)
and idiopathic epilepsy were the most common presenting
diagnoses, other causes included metabolic abnormalities, central
nervous system infections, brain tumors, cerebral dysgenesis, AED
dosing change, and drug overdose.

Emergency Department Interventions
Patients transported from the city presented in sustained SE to
the ED at a higher percentage than those transported from outside
(40.91% of Group A patients vs. 9.38% Group B patients;
p = 0.0008). Emergency department complications are shown in
Table 2b. Approximately 61% of patients experienced apnea,

Table 1: Variables adversely impacting outcome in children presenting to a PICU
Predictor Variable

Adjusted OR

95% CI

Recurrent Seizures during ICU Treatment

2.461

1.099-5.512

Refractory Status Epilepticus

3.858

1.062-14.022

Transport Apnea

4.546

1.859-11.118

Recurrent seizures in Clinical Teaching Units

5.003

1.800-13.910

8.087

1.343-48.693

12.438

3.418-45.265

Renal Failure in PICU
Cerebral Edema

ICU = intensive care unit; PICU = pediatric intensive care unit
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Table 2a: Transport and ED Management Duration of Patients with Status Epilepticus
Length of Time in hours
(Interquartile Range)

Total Number of Patients

Patients who returned
to baseline

Patients with New Deficits

Patients who died

p-value

Transport to ED

0.65 (0.37-1.73)

0.58 (0.36-1.37)

1.30 (0.47-2.53)

0.42 (0.31-2.29)

NS

ED Stay

2.67 (2.00-3.58)

2.48 (1.88-3.53)

3.31 (2.58-4.25)

2.31 (1.75-3.00)

NS

Table 2b: Transport and ED Complications of Patients with Seizures
Location of Management

Complication

Total Patients

Returned to Baseline

New Deficits

Death

p-value

Transport Management (n = 121)

Apnea

47

27

16

4

*p = 0.0054

Developed SE

26

20

6

0

NS

Refractory SE

10

7

2

1

NS

7

5

2

0

NS

78

60

14

4

NS

1

1

0

0

NS

40

32

8

0

NS

Failed 1st AED dose (n = 34)
ED Management (n = 128)

Apnea
Failed Intubation
Developed SE
Refractory SE

21

13

3

5

*p < 0.0001

Failed 1st AED dose (n = 105)

15

12

3

0

NS

*Significant p values. NS = not significant; ED = emergency department; SE = status epilepticus; AED = anti-epileptic drugs.

Table 3a: Duration of PICU SE Management and Relationship to Deficit Development and Mortality
Time (hours)

Returned to Baseline

Patients with New Deficits

Patients who Died

p-value

Seizure Duration (n = 176)

0.70 (0.42-1.13)

0.66 (0.12-1.38)

1.30 (0.42-2.50)

NS

Time to 1st AED (n = 181)

0.47 (0.25-1.37)

0.42 (0.17-0.88)

0.28 (0.10-0.75)

NS

Duration of Mechanical Ventilation (n = 125)

8.75 (3.95-21.62)

24.50 (12.12-102.70)

74.25 (27.58-150.10)

*p < 0.0001

Duration of Therapeutic Coma (n = 8)

5.73 (4.22-7.25)

30.29 (17.5-43.79)

77.38 (75.50-79.25)

*p = 0.0498

Length of Hospital Stay (n = 188)

97.08 (63.25-172.30)

253.33 (82.52-607.20)

564.38 (170.13-1769.72)

*p < 0.0001

Table 3b: SE Management and Complication Development in Relationship to SE Outcomes
Returned to Baseline
Type of Management

Complication During Length of Stay

Patients with
New Deficits

Patients who
Died

p-value

Central Venous Access (n = 25/189)

9

9

7

*p < 0.0001

Arterial Line (n = 25/189)

5

13

7

*p < 0.0001

Seizures on Arrival (n = 58/186)

40

13

5

NS

Recurrent Seizures (n = 98/189)

57

32

9

*p = 0.0021

Refractory Seizures (n = 17/189)

6

9

2

*p = 0.0056

Therapeutic Coma (n = 8/189)

2

4

2

*p = 0.0096

Ventilator-Induced Pneumonia (n = 18/125)

15

3

0

NS

1

0

0

NS

Post-Extubation Stridor (n = 26/125)

16

6

4

NS

Other Ventilator Complications (n = 34/125)

21

11

2

NS

AED-induced Respiratory Depression (n = 55/189)

44

8

3

NS

Extubation Failure (n = 1/125)

*Significant value; NS = not significant; SE = status epilepticus; AED = anti-epileptic drugs.
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Table 4: Impact of PICU Complications on SE Outcomes
Complication

n†

Returned to Baseline

Patients With New Deficits

Patients Who Died

Infection

87

56

24

7

NS

Renal Failure

11

2

4

5

*p < 0.0001

p value

Hyperthermia

49

28

17

4

NS

Acidosis

21

12

4

5

*p = 0.0022

Cardiac Arrhythmias

7

2

2

3

*p = 0.0002

Hypotension

8

2

3

3

*p = 0.0004

Pulmonary Edema

2

0

0

2

*p < 0.0001
*p = 0.0034

Hypoglycemia

6

1

3

2

Cerebral Edema

22

4

14

4

*p < 0.0001

Hepatic Failure

5

0

2

3

*p < 0.0001

2

0

1

1

*p = 0.0177

Increased ICP

11

3

3

5

*p < 0.0001

Apnea

10

6

2

2

NS

DIC

Anemia

19

8

7

4

*p = 0.0042

SIADH

11

3

7

1

*p = 0.0049

5

1

3

1

*p = 0.0486

Hypertension

4

1

0

3

*p < 0.0001

Other Complications

67

33

23

11

*p < 0.0001

Inadequate 1st AED Dose‡

68

50

14

4

NS

58.98 (37.00-182.74)

p < 0.0001

Respiratory Failure

Median PICU LOS

∙

189

24.43 (14.77-42.50)

50.42 (23.17-116.38)

NS = not significant; PICU = pediatric intensive care unit; SE = status epilepticus; DIC = Disseminated Intravascular Coagulation; ICP = intracranial
pressure; AED = anti-epileptic drugs; SIADH = syndrome of inappropriate anti-diuretic hormone ; LOS = length of stay.
*Significant p values.
†
n represents number of patients with specified complication out of total n = 189.
‡
Total n = 136. For all other complications, total n = 189.
∙
Median PICU Length of Stay (LOS) in hours with Interquartile Ranges in parentheses.

followed by 31% that developed SE in the ED, although they did not
lead to significant outcomes. Sixteen percent of patients developed
refractory SE in the ED, however, 62% returned to baseline
(Table 2b). Eighteen percent of patients who developed new deficits
experienced apnea in the ED, almost half the number of patients that
experienced apnea during transport. Mortality of SE patients in the
ED was significantly attributable to refractory SE (55%).
PICU Stay and Complications
The median duration of PICU stay was 34.38 hours (interquartile range, 16.25-59.17). The duration of transport (related to
geographical distribution) did not adversely influence outcome
variables. A similar proportion of patients from Winnipeg and
outside of Winnipeg were admitted to the PICU on each of the
three shifts (7 a.m. to 3 p.m., 3 p.m. to 11 p.m., and 11 p.m. to 7 a.m.).
The time of day at which the patients were admitted was not
significantly correlated with outcome. The most common indication for PICU admission was the need for mechanical ventilator
support. Patient mortality, followed by new deficit development,
was significantly correlated to longer duration of mechanical
ventilation and therapeutic coma and increased length of hospital
stay (Table 3a). Group B patients had significantly longer hospital
stays (p = 0.0396) and were mechanically ventilated longer
(p = 0.0037) than Group A counterparts residing within the city of
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Winnipeg (data not shown). Yet, the need for central venous
access or continuous arterial pressure monitoring also correlated
with poor outcomes (Table 3b). Patients with recurrent breakthrough seizures after hospitalization and those with refractory
recurrent breakthrough seizures had poorer outcomes than those
without recurrent seizures (Table 3b).
Many of the complications in the PICU had significant effects
on outcome, including renal failure, acidosis, cardiac arrhythmias,
hypotension, pulmonary edema, hypoglycemia, cerebral edema,
hepatic failure, disseminated intravascular coagulation, anemia,
SIADH, hypertension, respiratory failure, and other complications
(Table 4). The occurrence of cerebral edema and the presence of
anemia were significantly associated with a poor outcome in
Group B patients (p = 0.0104 and p = 0.0381, respectively).
DISCUSSION
To our knowledge, this is the first study to review outcome
variables of children presenting in SE at a single-center PICU
while determining its risk factors, management and overall outcome. Based on the information analyzed in the small number of
patients in this cohort, we were unable to correlate etiology to
PICU outcomes. Although SE has a heterogeneous etiology,
children with atypical febrile seizures constitute a significantly
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large proportion of patients requiring intensive care. In fact, idiopathic epilepsy and febrile status epilepticus combined accounted
for 50% of the patients admitted to the PICU. The incidence of SE
decreases by 25-40% based on exclusion of febrile SE, indicative of
its common etiology.17 In our study, etiologies could be surmised
from the evolution of illness in our PICU patients. Infection was a
major complication for 87 of 189 patients (Table 3). Although there
was no significant effect on outcome and most patients returned to
baseline, this data does offer insight into common etiologies of SE.
In a prospective cohort of patients with febrile SE reported by
Shinnar et al.,18 the short-term outcome was considered good
because the morbidity and mortality were low. It is known that viral
triggers are associated with febrile SE, however, recent reports link
infection with afebrile SE.19 In our cohort of patients admitted to
the PICU, 9% were identified as having a primary central nervous
system infection (Figure 1). Although infectious agents were not
identified, our data is consistent with studies demonstrating that
several viruses, including human herpes virus-6, human herpes
virus-7 and others, are causes of febrile SE.19 While the immediate
outcomes of SE following such primary infections appear to be
good, the long-term outcomes with regard to behavior, cognitive
function, and the delayed development of epilepsy remain unclear.
Paediatric post-traumatic brain injury patients are at increased risk
of subclinical and clinical SE detected via continuous EEG
monitoring.20 Brain injury sequelae include PICU complications
seen in this study – seizures evolving to SE, increased inracranial
pressure, hyperthermia, cerebral edema, and SIADH,21-23 which
significantly attributed to SE outcomes. It is unknown at this time if
patients in our study manifested these complications based upon an
established diagnosis of traumatic or anoxic brain injury, although
4% of our cases occurred after trauma (Figure 1). However, in
retrospect, it is suspected that they developed aforementioned
sequelae, including SE, due to brain injury.
Aggressive first-line treatment to stabilize patients in SE has
improved yet still remains challenging, given multiple etiologies,
e.g. 27% of our patients presented in febrile SE (Figure 1), possibly related to prolonged time in transport or lack of immediate
administration of AED. The addition of extraneous variables,
including prolonged transport times and failure of AED administration tend to complicate treatment in the ED and can lead to
subsequent PICU admission. Transport times, in our study, was
not significant in determining outcomes, likely due to the number
of patient records reviewed. Despite the p-values, it is yet noteworthy to mention that longer transport times may still lead to
development of new deficits in patients. Additionally, transport
apnea was a significant complication (Table 1). Apnea is a known
complication of emergency transport and can lead to increased
mortality.24 Future retrospective studies with a larger cohort might
yield more insight into the etiology, as well as transport times and
time to first AED administration as possible risk factors for SE
onset and development of SE and complications.
During ED and PICU management of SE, refractory and
recurrent SE were significant complications throughout the
hospital course that adversely affect outcomes (Tables 1b and 2b).
The mortality rate of patients who develop in-hospital SE vary
from 32%-60%, however, there are no studies comparing this to
mortality rates of those who develop out-of-hospital SE.25 There
is virtually no data supporting that the incidence of prolonged and
refractory SE may be influenced by geographic location (countryor region-specific data) and that the cause of SE cannot be
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ascertained based on increased transport times to a medical facility
from a rural area.
Despite differences in initial treatments provided at the
patient’s geographic location, rates of admission to the PICU did
not differ. Roughly 15% of all patients received inadequate
dosages of their AED medications, at the site of initial treatment as
well as in the ED. In addition to inadequate dosing, a significant
proportion of children admitted to the PICU received not only
inadequate doses of the rescue medication (benzodiazepine) but
subsequent doses of first and second line AEDs administered
during transport and in the ED. The reasons for this remain
unclear, but could be related to caution regarding the problem of
respiratory depression secondary to the use of combinations of
benzodiazepines and phenobarbital. As this phenomenon was not
consistently observed, variables such as individual physician
preferences, calculations, and weight errors may exist in treatment
administration. All treatment protocols issued to parents and used
by the prescribing practice, by transport teams, in the ED, and the
PICU should emphasize the importance of ascertaining patient
weight accurately in order to reduce the chances of inadequate
treatment. Inadequate dosing may have been an unrecognized
variable that influenced the occurrence of self-sustained SE. This
observation has been made in other studies.11
The development of refractoriness to AED therapy remains one
of the enduring challenges in the management of SE, especially in
the ICU setting.26,27 In our patient cohort, we identified 17 (9%)
patients admitted to the PICU who evolved to a state of treatmentrefractory status epilepticus. Of these, eight (~50%) required the
induction of therapeutic coma using pentobarbital. Four patients
were left with fresh neurological deficits, and two patients died. We
used high-dose suppression therapy such as pentobarbital and
midazolam with EEG monitoring for management of refractory
SE as suggested for treatment refractoriness to conventional
measures.15,28 The role of newer therapeutic alternatives for the
management of status epilepticus has been described.15,29 Several
case series and open label trials have reported success with use of
AEDs including intravenous valproic acid,30-32 topiramate33-35 and
levetiracetam.30,36,37 Increasing experience with these may provide
additional options, prior to the consideration of high-dose suppression therapy in the ICU. Other paediatric SE studies suggest that the
outcome of patients treated with high-dose suppression therapy is
independent of the specific coma-inducing agents or the extent of
EEG burst suppression, suggesting that the primary etiology may be
a key determinant of outcome.38 Additionally, it is known that
pentobarbital causes hypotension and is associated with nosocomial
infections due to white blood cell dysfunction.39
Paediatric ICU complications associated with adverse outcomes include infection, cerebral edema, increased ICP, and renal
failure. Infection has already been discussed as a complication of
the etiology of the seizure. Increased ICP, SIADH, and cerebral
edema are all related to SE etiology, specifically brain injury.
Renal failure is a less specific seizure complication, but significant
nevertheless to SE outcomes in this study. Acute renal failure is a
commonly associated complication of seizures and SE, likely due
to rhabdomyolysis from increased muscular activity during
seizure. Moreover, infection increases susceptibility to acute renal
failure.40 Creatine kinase levels were not measured in any of the
patients in our study, especially with either increased refractory
or recurrent seizures, however, it is likely that these patients
developed renal failure. The cause of renal failure in our patients is
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unknown but likely secondary to the seizure and musculoskeletal
overactivity. With increased confidence intervals for renal failure
and cerebral edema odds ratios, more data would need to be
collected in order to determine if renal failure and cerebral edema
are variables truly indicative of worsening outcomes.
There are few studies of long-term outcomes among children
who experienced SE requiring PICU admission, although it has
been reported that children with EEG-monitored status epilepticus
have worsened outcomes.41 In general, our retrospective data point
to a favorable outcome for the majority (~70%), and considerable
morbidity in the form of added neurological deficits (24%), with
mortality rates that are very similar to other reported studies.11 The
risk of subsequent epilepsy (13-74%), and of recurrent SE (3-56%)
varies across published studies and meta-analyses.42
There are several limitations to this study: inclusion of a small
number of subjects, limiting the statistical analysis; incomplete or
missing datasets; a selection bias towards the sickest patients in SE;
seizure types that could not be classified accurately from the
abstracted data; unclassified types of SE; outcomes that were chosen
upon discharge leading to deficits that may not have been recorded;
failure to correlate longer transport times and PICU stay with new
deficits acquired during transport; and, finally, long-term follow-up
outcomes with deficit specification remain unreported. Additionally,
in Table 2a, new deficits acquired during transport did not correlate
with longer transport times and PICU stays. However, this would be
better addressed with a prospective analysis.
CONCLUSIONS
Our clinical findings impart a sense of urgent need to establish
risk factors of paediatric SE and its complications during the
hospital course, recognize the challenges in the management of
paediatric status epilepticus to prevent the significant morbidity
associated with epilepsy, as well as the long-term comorbidities in
the form of behavioral and neurocognitive impairments.
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